2 Einträge von mit manufacturing society
www.sipbb.ch
Datum der Indexierung 04.10.2024 19:40:55
Subdomain:
extern (outbound) Link/Domain 9 in www.sipbb.ch
intern (inbound) Link/Domain www.sipbb.ch
Alle Links in alle Links in www.sipbb.ch
Kombination Keywords with that | rupture factory | park swiss | risk project | patients aaas | biel/bienne they | switzerland aortic | abdominal center | data switzerland-innovation.com | smart innovation |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Manufacturing Center Swiss Battery Technology Center Swiss Healthtech Center Swiss Smart Factory technologie Ingénierie Fabrication additive Park Biel/Bienne Locataires Événements Startup accélérator Incubator À propos Mission Downloads Emplois & Car society the overall incidence shows an increasing tendency. Maximum AAA diameter is an imperfect measure of AAA rupture risk, since some large AAAs remain intact throughout a patient’s lifetime, while some small AAAs rupture (earl
Text Inhalt Text aus URL
Log Metriken 10375
Subdomain:
extern (outbound) Link/Domain 9 in www.sipbb.ch
intern (inbound) Link/Domain www.sipbb.ch
Alle Links in alle Links in www.sipbb.ch
Kombination Keywords with that | rupture factory | park swiss | risk project | patients aaas | biel/bienne they | switzerland aortic | abdominal center | data switzerland-innovation.com | smart innovation |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Manufacturing Center Swiss Battery Technology Center Swiss Healthtech Center Swiss Smart Factory technologie Ingénierie Fabrication additive Park Biel/Bienne Locataires Événements Startup accélérator Incubator À propos Mission Downloads Emplois & Car society the overall incidence shows an increasing tendency. Maximum AAA diameter is an imperfect measure of AAA rupture risk, since some large AAAs remain intact throughout a patient’s lifetime, while some small AAAs rupture (earl
Text Inhalt Text aus URL
Log Metriken 10375
www.cslbehring.ch
Datum der Indexierung 04.10.2024 23:31:04
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Manufacturing Regulatory Compliance Every day at CSL Behring, we work as if someone’s life depends on it, because it does. Learn More CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions. Lea Society of Hematology (ASH) 2023 Annual Meeting and Exposition continue to reinforce the potential long-lasting efficacy and safety of HEMGENIX® and the ongoing benefit of this treatment for people living with hemophilia B. About
Text Inhalt Text aus URL
Log Metriken 86111
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Manufacturing Regulatory Compliance Every day at CSL Behring, we work as if someone’s life depends on it, because it does. Learn More CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions. Lea Society of Hematology (ASH) 2023 Annual Meeting and Exposition continue to reinforce the potential long-lasting efficacy and safety of HEMGENIX® and the ongoing benefit of this treatment for people living with hemophilia B. About
Text Inhalt Text aus URL
Log Metriken 86111